This study investigates the dynamics of Monkeypox virus (MPXV) through a novel theoretical framework that extends classical epidemic threshold theory. The dual threshold theory is introduced, highlighting the interplay between the time-dependent basic reproduction number and the susceptible population density. Epidemic initiation is shown to occur when the time dependent reproductive number is greater than the threshold value of one and the susceptible population density at any time is greater than the critical threshold density of susceptibles. The model incorporates waning immunity from prior smallpox vaccination and immunity loss from previous MPXV infections, revealing complex epidemic behaviors such as oscillatory waves, prolonged outbreaks, and extended inter-epidemic periods under high transmission scenarios. Sensitivity analyses identify key drivers of epidemic initiation and progression, emphasizing the critical influence of waning immunity and zoonotic reservoirs. Public health implications underline the importance of targeted vaccination campaigns, rodent control, and continuous surveillance to reduce epidemic risks and prevent resurgence. This study provides actionable insights for managing MPXV outbreaks, while the dual threshold framework offers a robust theoretical foundation for understanding the dynamics of waning of vaccine cross immunity and zoonotic diseases.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

My research does not involve the use of human data or human subjects. It focuses on theoretical modeling and mathematical analysis of disease dynamics, particularly the impact of waning immunity from smallpox vaccination on monkeypox transmission. There is no collection, analysis, or use of human data, patient records, or biological samples

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present work are contained in the manuscript